Lack of chronic toxicity and carcinogenicity of dietary administrated catechin mixture in wistar hannover GALAS rats

Journal of Toxicological Sciences

Volumn 36, Issue 3, 2011, Pages 297-311

  Yoshida, Midori ^a   Takahashi, Miwa ^a   Inoue, Kaoru ^a   Nakae, Dai ^b   Nishikawa, Akiyoshi ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Carcinogenicity; Catechin mixutre; Chronic toxicity; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CALCIUM; CATECHIN; CHOLESTEROL; CREATININE; CYTOCHROME P450 3A2; HEMOGLOBIN; POTASSIUM; SODIUM;

ADAPTATION; ADRENAL GLAND; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; BRAIN; CALCIUM BLOOD LEVEL; CALORIC INTAKE; CANCER INCIDENCE; CARCINOGENICITY; CHOLESTEROL BLOOD LEVEL; CHRONIC TOXICITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENDOMETRIUM POLYP; ERYTHROCYTE; FEMALE; FOOD INTAKE; HEART; HEMANGIOMA; HEMATOCRIT; HYPOPHYSIS; HYPOPHYSIS ADENOMA; KIDNEY; LEUKOCYTE; LEYDIG CELL TUMOR; LIVER; LIVER CELL; LIVER WEIGHT; MALE; MAXIMUM TOLERATED DOSE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NONHUMAN; ORGAN WEIGHT; OVARY; PAPILLOMA; POTASSIUM BLOOD LEVEL; PROSTATE; RAT; SODIUM BLOOD LEVEL; SPLEEN; TESTIS; THYROID ADENOMA; UTERUS;

RATTUS;

EID: 79958031774     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.297     Document Type: Article

References (21)

1. Adhami, V.M., Ahmad, N., Mukhtar, H. and Ahmad, N. (2003): Molecular targets for green tea in prostate cancer prevention. J. Nutr., 133, 2417S-2424S.
2. de Whalley, C.V., Rankin, S.M., Hoult, J.R., Jessup, W. and Leake, D.S. (1990): Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol., 39, 1743-1750.
3. Doss, M.X., Potta, S.P., Hescheler, J. and Sachinidis, A. (2005): Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J. Nutr. Biochem., 16, 259-266.
4. Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B. and Kromhout, D. (1993): Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet, 342, 1007-1011.
5. Jang, E., Park, Y. and Chung, W.G. (2004): Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats. Food Chem. Toxicol., 42, 1749-1756.
6. Jian, L., Xie, L.P., Lee, A.H. and Binns, C.W. (2004): Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int. J. Cancer, 108, 130-135.
7. Joint FAO/WHO Meeting of Pesticide Residues (JMPR) (2006): Guidance on the interpretation of hepatocellular hypertrophy. Summary report.
8. Khan, N., Adhami, V.M. and Mukhar, H. (2010): Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr. Relat. Cancer, 17, R39-R52.
9. Khan, N., Afaq, F. and Mukhtar, H. (2008): Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox Signal., 10, 475-510.
10. Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H. (2006): Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res., 66, 2500-2505.
11. Kumar, N., Shibata, D., Helm, J., Coppola, D. and Malafa, M. (2007): Green tea polyphenols in the prevention of colon cancer. Front. Biosci., 12, 2309-2315.
12. MHLW (Ministry of Health Labor Welfare of Japan) (1996): Guidelines for Designation of food additives and for revision of Standard for Use of Food Additives. Japan Food Additive Association.
13. Shimizu, M., Shirakami, Y. and Moriwaki, H. (2008): Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Int. J. Mol. Sci., 9, 1034-1049.
14. Siddiqui, I.A., Adhami, V.M., Saleem, M. and Mukhtar, H. (2006): Beneficial effects of tea and its polyphenols against prostate cancer. Mol. Nutr. Food Res., 50, 130-143.
15. Sim, H.G. and Cheng, C.W. (2005): Changing demography of prostate cancer in Asia. Eur. J. Cancer, 41. 834-845.
16. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989): Beyond cholesterol. Modifications of lowdensity lipoprotein that increase its atherogenicity. N. Engl. J. Med., 320, 915-924.
17. Stuart, E.C., Scandyln, M.J. and Rosengren, R.J. (2006): Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci., 79, 2329-2336.
18. Takami, S., Imai, T., Hasumura, M., Cho, Y.M. and Hirose, M. (2008): Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats. Food Chem. Toxicol., 46, 2224-2229.
19. Verschovle, R.D., Steward, W.P. and Gescher, A.J. (2007): Putative cancer chemopreventive agents of dietary origin - how safe are they? Nutr. Cnacer, 59, 152-162.
20. Verschovle, R.D., Steward, W.P. and Gescher, A.J. (2007): Putative cancer chemopreventive agents of dietary origin - how safe are they? Nutr. Cnacer, 59, 152-162
21. Yang, C.S., Maliakal, P. and Meng, X. (2002): Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol., 42, 25-54.